Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study)

Background: In vitro, animal, biological and observational clinical studies suggest that some hormonal methods, particularly depot medroxyprogesterone acetate – DMPA, may increase women’s risk of HIV acquisition. DMPA is the most common contraceptive used in many countries worst affected by the HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmeyr, G. Justus, Morrison, Charles S., Baeten, Jared M., Chipato, Tsungai, Donnell, Deborah, Gichangi, Peter, Mugo, Nelly, Nanda, Kavita, Rees, Helen, Steyn, Petrus, Taylor, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771152/
https://www.ncbi.nlm.nih.gov/pubmed/29355224
http://dx.doi.org/10.12688/gatesopenres.12775.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771152/
https://www.ncbi.nlm.nih.gov/pubmed/29355224
http://dx.doi.org/10.12688/gatesopenres.12775.2

Ejemplares similares